Jasper Therapeutics to Present at Upcoming Conferences
REDWOOD CITY, Calif., Sept. 23, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with stem cell therapies, today announced that the Company will be participating in the following conferences in September. Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference (New York City) Ronald Martell, CEO, will participate in […]
Stem Cell Research for Brain Repair
Dr. Piotr Walczak, Professor at the Department of Diagnostic Radiology and Nuclear Medicine at the University of Maryland Baltimore, uses interdisciplinary approaches to study neurological disorders and advance therapeutics by implementing image-guided neuro-interventions. There are more than 600 neurological disorders that pose a major global burden. Dr. Walczak and his lab study several of these […]
Talaris Therapeutics to Present at William Blair’s Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event
BOSTON and LOUISVILLE, Ky., Sept. 21, 2022 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that Scott Requadt, Chief Executive Officer of Talaris, will present at […]
One Man’s Spinal Cord Injury & His Approach To Recovery with the Help of Stem Cells
Amazing story of a man who was in a motorcycle accident and was told he was paralyzed. Here’s a glimpse of his journey to healing and the use of stem cells to help his recovery. Video Transcript: I was desert racing in Nevada, Vegas to Reno and on a dirt bike, 500 mile race and […]
Fantastic Stem Cells and Where to Find Them
What if we could trick stem cells into thinking they were young again? What would the impact be on human health and aging? Shiri Gur-Cohen, Ph.D., shares her work in this presentation… Video Transcript: [MUSIC] Stem cells holds the power for generation, but stem cells can age. What if I can tell you that we […]
Is stem cell therapy covered by insurance?
Stem cell therapy is a new and promising treatment for a variety of diseases and injuries, but it can also be very expensive. Insurance companies are starting to cover stem cell therapy, but there are still many restrictions. As this industry continues to grow, we hope to see more major insurance carriers start to cover […]
StemExpress Opens New Collection Center in Biotech Hub of Boston, MA
CAMBRIDGE, Mass., Sept. 15, 2022 /PRNewswire/ — StemExpress is excited to announce the opening of their newest StemExpress cell collection center in Boston, Massachusetts. StemExpress is relocating from Arlington, MA to the prestigious research hub of Cambridge, MA. The move promises more partnerships and better logistics for client needs, opening doors for more scalable cell […]
Life-Saving Innovations in Cancer-Fighting Stem Cell Transplants and Pioneering Research in HIV, Autism and Cerebral Palsy to be Featured at World Cord Blood Day 2022
TUCSON, Ariz., Sept. 14, 2022 /PRNewswire/ — We are pleased to announce World Cord Blood Day 2022 (WCBD 2022) will take place on November 15th, featuring a free online medical conference and educational events worldwide. This year’s official online conference will highlight innovations in cancer-fighting stem cell transplants using cord blood, as well as ground-breaking […]
Regenerative Medicine Treatment Options
In this webinar replay, Dr. Siddharth Tambar from Chicago Arthritis and Regenerative Medicine reviews regenerative treatment options in details and answers audience questions. Video Transcript: Hello, everyone – this is Siddharth Tambar from Chicago Arthritis and Regenerative Medicine. Welcome to our webinar today on regenerative medicine treatments. As I’m talking, I’ve got a little bit […]
Lyell Immunopharma Presents First in Human Trial Design of LYL797 at ESMO 2022
SOUTH SAN FRANCISCO, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company dedicated to developing curative cell therapies for patients with solid tumors, announced today that a poster describing the first-in-human Phase 1 trial design for LYL797, Lyell’s ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic […]